A pilot study of stereotactic body radiotherapy (SBRT) combined with a PD-L1 antibody durvalumab (D) and a CTLA-4 antibody tremelimumab (T) to treat metastatic anaplastic thyroid cancer (ATC) Meeting Abstract
| Authors: | Lee, N.; Tsai, C. J.; Riaz, N.; Wu, V.; Brinkman, T.; Zhi, W.; Fetten, J.; Ho, A.; Pfister, D. G.; Sherman, E. |
| Abstract Title: | A pilot study of stereotactic body radiotherapy (SBRT) combined with a PD-L1 antibody durvalumab (D) and a CTLA-4 antibody tremelimumab (T) to treat metastatic anaplastic thyroid cancer (ATC) |
| Meeting Title: | 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 105 |
| Issue: | 1 Suppl. |
| Meeting Dates: | 2019 Sep 15-18 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-09-01 |
| Start Page: | S19 |
| Language: | English |
| ACCESSION: | WOS:000485671502448 |
| DOI: | 10.1016/j.ijrobp.2019.06.416 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 37 -- Source: Wos |
